Metastatic bone pain: treatment options with an emphasis on bisphosphonates

被引:0
作者
Roger von Moos
Florian Strasser
Silke Gillessen
Kathrin Zaugg
机构
[1] Kantonsspital Graubünden,Medical Oncology
[2] Kantonsspital,Palliative Medicine Section Oncology, Department of Internal Medicine
[3] University Hospital,Department of Radiation Oncology
[4] Kantonsspital,Oncology–Haematology
来源
Supportive Care in Cancer | 2008年 / 16卷
关键词
Metastatic bone disease; Skeletal-related events; Bone pain; Bisphosphonates; Analgesic;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1105 / 1115
页数:10
相关论文
共 358 条
  • [1] Anselmetti GC(2005)Treatment of painful compression vertebral fractures with vertebroplasty: results and complications Radiol Med (Torino) 110 262-272
  • [2] Corgnier A(2003)Short-term, high-dose pamidronate induced acute tubular necrosis: the postulated mechanisms of bisphosphonate nephrotoxicity Am J Kidney Dis 41 E18-221
  • [3] Debernardi F(1992)A review of local radiotherapy in the treatment of bone metastases and cord compression Int J Radiat Oncol Biol Phys 23 217-493
  • [4] Regge D(1996)Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma N Engl J Med 334 488-3
  • [5] Banerjee D(1999)Bisphosphonates for metastatic bone pain Support Care Cancer 7 1-485
  • [6] Asif A(2001)Bisphosphonates in the treatment of metastatic breast cancer J Mammary Gland Biol Neoplasia 6 477-407
  • [7] Striker L(2002)Bisphosphonates for cancer patients: why, how and when? Support Care Cancer 10 399-312
  • [8] Preston RA(2004)Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer Pain 111 306-7
  • [9] Bourgoignie JJ(2005)Preclinical perspectives on bisphosphonate renal safety Oncologist 10 3-1679
  • [10] Roth D(2003)Renal failure with the use of zoledronic acid N Engl J Med 349 1676-21